This compound is a pharmaceutical intermediate featuring an amide functional group attached to a heterocyclic ring system, with moderate polarity and low lipophilicity as indicated by its physicochemical profile. Its primary significance lies in its use as a chemical building block for the production of more complex pharmaceutical agents.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 136738-23-3
(Z)-Benzyl 7-((1R,2R,3R,5S)-2-(4,4-difluoro-3-hydroxyoctyl)-5-hydroxy-3-((tetrahydro-2H-pyran-2-yl)oxy)cyclopentyl)hept-5-enoate
pharmaceutical intermediate
Potassium vinyltrifluoroborate
pharmaceutical intermediate
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-3-fluorooxolan-2-yl]purin-6-yl]benzamide
Pharmaceutical intermediate for oligonucleotide synthesis
4-(4-HYDROXYMETHYL-3-METHOXYPHENOXY)-BUTYRIC ACID
HMPB linker for solid-phase peptide synthesis
4-Amino-6-methyl-4,5-dihydro-1,2,4-triazin-3(2H)-one--hydrogen chloride (1/1)
Pharmaceutical intermediate
N-(6-methyl-3-oxo-2,5-dihydro-1,2,4-triazin-4-yl)acetamide
NCSCAWXVGUIUEY-UHFFFAOYSA-N
CC1=NNC(=O)N(C1)NC(=O)C
—